In contrary, downregulation of SATB2 expression was shown to be associated with enhanced cell growth, metastasis and poor prognosis in CRC56, 57 and overexpression of SATB2 repressed cancer cell proliferation, migration and invasion by inhibiting ERK558. Here, SATB2 is linked to cancer.